Cargando…

Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor

A complex conformational energy landscape determines G-protein-coupled receptor (GPCR) signalling via intracellular binding partners (IBPs), e.g., G(s) and β-arrestin. Using (13)C methyl methionine NMR for the β(1)-adrenergic receptor, we identify ligand efficacy-dependent equilibria between an inac...

Descripción completa

Detalles Bibliográficos
Autores principales: Solt, Andras S., Bostock, Mark J., Shrestha, Binesh, Kumar, Prashant, Warne, Tony, Tate, Christopher G., Nietlispach, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702606/
https://www.ncbi.nlm.nih.gov/pubmed/29176642
http://dx.doi.org/10.1038/s41467-017-02008-y
_version_ 1783281556443365376
author Solt, Andras S.
Bostock, Mark J.
Shrestha, Binesh
Kumar, Prashant
Warne, Tony
Tate, Christopher G.
Nietlispach, Daniel
author_facet Solt, Andras S.
Bostock, Mark J.
Shrestha, Binesh
Kumar, Prashant
Warne, Tony
Tate, Christopher G.
Nietlispach, Daniel
author_sort Solt, Andras S.
collection PubMed
description A complex conformational energy landscape determines G-protein-coupled receptor (GPCR) signalling via intracellular binding partners (IBPs), e.g., G(s) and β-arrestin. Using (13)C methyl methionine NMR for the β(1)-adrenergic receptor, we identify ligand efficacy-dependent equilibria between an inactive and pre-active state and, in complex with G(s)-mimetic nanobody, between more and less active ternary complexes. Formation of a basal activity complex through ligand-free nanobody–receptor interaction reveals structural differences on the cytoplasmic receptor side compared to the full agonist-bound nanobody-coupled form, suggesting that ligand-induced variations in G-protein interaction underpin partial agonism. Significant differences in receptor dynamics are observed ranging from rigid nanobody-coupled states to extensive μs-to-ms timescale dynamics when bound to a full agonist. We suggest that the mobility of the full agonist-bound form primes the GPCR to couple to IBPs. On formation of the ternary complex, ligand efficacy determines the quality of the interaction between the rigidified receptor and an IBP and consequently the signalling level.
format Online
Article
Text
id pubmed-5702606
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57026062017-11-29 Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor Solt, Andras S. Bostock, Mark J. Shrestha, Binesh Kumar, Prashant Warne, Tony Tate, Christopher G. Nietlispach, Daniel Nat Commun Article A complex conformational energy landscape determines G-protein-coupled receptor (GPCR) signalling via intracellular binding partners (IBPs), e.g., G(s) and β-arrestin. Using (13)C methyl methionine NMR for the β(1)-adrenergic receptor, we identify ligand efficacy-dependent equilibria between an inactive and pre-active state and, in complex with G(s)-mimetic nanobody, between more and less active ternary complexes. Formation of a basal activity complex through ligand-free nanobody–receptor interaction reveals structural differences on the cytoplasmic receptor side compared to the full agonist-bound nanobody-coupled form, suggesting that ligand-induced variations in G-protein interaction underpin partial agonism. Significant differences in receptor dynamics are observed ranging from rigid nanobody-coupled states to extensive μs-to-ms timescale dynamics when bound to a full agonist. We suggest that the mobility of the full agonist-bound form primes the GPCR to couple to IBPs. On formation of the ternary complex, ligand efficacy determines the quality of the interaction between the rigidified receptor and an IBP and consequently the signalling level. Nature Publishing Group UK 2017-11-27 /pmc/articles/PMC5702606/ /pubmed/29176642 http://dx.doi.org/10.1038/s41467-017-02008-y Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Solt, Andras S.
Bostock, Mark J.
Shrestha, Binesh
Kumar, Prashant
Warne, Tony
Tate, Christopher G.
Nietlispach, Daniel
Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor
title Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor
title_full Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor
title_fullStr Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor
title_full_unstemmed Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor
title_short Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound β(1)-adrenergic receptor
title_sort insight into partial agonism by observing multiple equilibria for ligand-bound and g(s)-mimetic nanobody-bound β(1)-adrenergic receptor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702606/
https://www.ncbi.nlm.nih.gov/pubmed/29176642
http://dx.doi.org/10.1038/s41467-017-02008-y
work_keys_str_mv AT soltandrass insightintopartialagonismbyobservingmultipleequilibriaforligandboundandgsmimeticnanobodyboundb1adrenergicreceptor
AT bostockmarkj insightintopartialagonismbyobservingmultipleequilibriaforligandboundandgsmimeticnanobodyboundb1adrenergicreceptor
AT shresthabinesh insightintopartialagonismbyobservingmultipleequilibriaforligandboundandgsmimeticnanobodyboundb1adrenergicreceptor
AT kumarprashant insightintopartialagonismbyobservingmultipleequilibriaforligandboundandgsmimeticnanobodyboundb1adrenergicreceptor
AT warnetony insightintopartialagonismbyobservingmultipleequilibriaforligandboundandgsmimeticnanobodyboundb1adrenergicreceptor
AT tatechristopherg insightintopartialagonismbyobservingmultipleequilibriaforligandboundandgsmimeticnanobodyboundb1adrenergicreceptor
AT nietlispachdaniel insightintopartialagonismbyobservingmultipleequilibriaforligandboundandgsmimeticnanobodyboundb1adrenergicreceptor